Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists

By Iyengar Srinivas   Rabbani LeRoy  

Journal of Thrombosis and Thrombolysis, Vol. 27, Iss. 3, 2009-04 ,pp. : 300-306

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y 12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates

By Klinkhardt U.   Kuczka K.   Harder S.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 251-257

Elsevier

Access to resources Recommend Favorite

Erratum to: Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation

By Rollini Fabiana   Tello-Montoliu Antonio   Patel Ronakkumar   Darlington Andrew   Wilson Ryan   Franchi Francesco   Muñiz-Lozano Ana   Desai Bhaloo   Bender Norbert   Sakariassen Kjell   Angiolillo Dominick  

Journal of Thrombosis and Thrombolysis, Vol. 37, Iss. 3, 2014-04 ,pp. : 358-358

Springer Publishing Company

Access to resources Recommend Favorite

Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms

By Kar Rakhee  

Platelets, Vol. 24, Iss. 4, 2013-06 ,pp. : 297-302

Informa Healthcare

Access to resources Recommend Favorite

Benefit of ADP Receptor Antagonists in Atherothrombotic Patients: New Evidence

By  

Cerebrovascular Diseases, Vol. 11, Iss. 2, 2001-04 ,pp. : 5-10

Karger

Access to resources Recommend Favorite